Category - Executive Moves

Executive Moves

Long-time research analyst Anthony Petrone joins Mizuho Americas

Anthony Petrone Mizuho Americas hired Anthony Petrone as a managing director, senior medical devices, diagnostics and therapeutics equity research analyst. Mr. Petrone has more than 16 years of experience in...

March 28, 2022

Executive Moves

Long-time healthcare investment banker Jim Alfaro joins JMP

Jim Alfaro has joined JMP Securities as a managing director, healthcare investment banker, after a nearly 15-year stint with Maxim Group.

March 22, 2022

Executive Moves

Long-time healthcare investment banker Kee Colen joins Cantor Fitzgerald

Kee Colen has joined Cantor Fitzgerald as a managing director, healthcare investment banking, from Raymond James.

March 21, 2022

Executive Moves

Sigyn Therapeutics names leading nephrologist Dr. H. David Humes to SAB

Sigyn Therapeutics (OTC:SIGY) appointed internationally recognized nephrologist, H. David Humes, M.D., to its scientific advisory board. Dr. Humes recently played an instrumental role in the oversight of preclinical...

March 15, 2022

Executive Moves

Sigyn appoints internationally recognized nephrologist Dr. Alexander Yevzlin to SAB

Sigyn Therapeutics (OTC:SIGY) appointed Alexander Yevzlin, M.D., currently prof. of medicine and director of interventional nephrology at the University of Michigan, to its scientific advisory board. Dr...

March 9, 2022

Executive Moves

Graphite Bio names biotech analyst Alethia Young as CFO

Alethia Young Graphite Bio (NASDAQ:GRPH) appointed Alethia Young as CFO, effective April 1, to oversee the company’s finance, investor relations and corporate communications functions, and to play a key role in...

March 4, 2022

Executive Moves

Sigyn Therapeutics names accomplished financial executive Jeremy Ferrell as CFO

Sigyn Therapeutics (OTC:SIGY) appointed Jeremy Ferrell as CFO, effective March 9, 2022, with overall responsibility for operational finance, budgeting, and financial reporting, as well as helping manage Sigyn’s...

March 2, 2022

Executive Moves

Pipeline Therapeutics appoints Eef Schimmelpennink to board

Evert Schimmelpennink Closely-held Pipeline Therapeutics named Evert (Eef) Schimmelpennink to its board. Mr. Schimmelpennink is a seasoned biotechnology executive with close to 25 years of experience spanning research...

February 22, 2022

Executive Moves

Hepion names world-renowned hepatologist, Dr. Eddie Cheung, to lead strategic medical affairs in Asia

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Eddie Cheung, M.D., FACG, to lead the company’s strategic medical affairs in Asia, a newly-created position. Dr. Cheung will explore and identify possible...

February 15, 2022

Executive Moves

Altamira updates RNA therapeutics program with new CDO, NIH grant

Altamira Therapeutics (NASDAQ:CYTO), in a business update on its development activities in RNA therapeutics, appointed Covadonga Pañeda, Ph.D., as chief development officer for RNA therapeutics, effective in early April...

January 13, 2022

Category - Executive Moves

Long-time research analyst Anthony Petrone joins Mizuho Americas

Long-time healthcare investment banker Jim Alfaro joins JMP

Long-time healthcare investment banker Kee Colen joins Cantor Fitzgerald

Sigyn Therapeutics names leading nephrologist Dr. H. David Humes to SAB

Sigyn appoints internationally recognized nephrologist Dr. Alexander Yevzlin to SAB

Graphite Bio names biotech analyst Alethia Young as CFO

Sigyn Therapeutics names accomplished financial executive Jeremy Ferrell as CFO

Pipeline Therapeutics appoints Eef Schimmelpennink to board

Hepion names world-renowned hepatologist, Dr. Eddie Cheung, to lead strategic medical affairs in Asia

Altamira updates RNA therapeutics program with new CDO, NIH grant

General

More